Exeporfinium chloride: Phase I data

A double-blind, placebo-controlled, U.S. Phase I trial in 48 healthy volunteers with colonized nasal S. aureus showed that 0.5 and 2 mg/g intranasal exeporfinium chloride in 2% and 4% gel formulations...